Résultats de la recherche - Yan-Liang Lin

  • Résultat(s) 1 - 1 résultats de 1
Affiner les résultats
  1. 1
    Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors

    Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors par Yi-Chiu Kuo, Hao-Kang Li, Tai-Sheng Wu, Ying Ru, Chia-Yun Lee, Pei-Ju Leng, Yi-Chun Hsieh, Yun-Jung Chiang, Zih-Fei Cheng, Yan-Liang Lin, Shih-Chia Hsiao, Sai-Wen Tang

    Publié 2025-07-01

    Background Targeting epidermal growth factor receptor (EGFR) has become a strategic approach in cancer therapy, using various modalities including chimeric antigen receptor (CAR)-αβT cell therapies. Despite significant advancements in autologous CAR-αβT cell therapies in B-cell lymphoma, current cel...

    Description complète

    Accéder au texte intégral
    Article

    Ajouter aux favoris
    Enregistré dans:

Outils de recherche: